PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.\', \'Reference and Surveillance Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.\', \'Innovation and Technology Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.\', \'Centre for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Human Toxicology, Nova Medical School Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.\', \'Instituto Gulbenkian de Ciência (IGC), Oeiras, Portugal.\', \'Department of Epidemiology, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.\', \'Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisbon, Portugal.\', \'Public Health Unit, Primary Care Cluster of Baixo Vouga, Central Regional Health Administration, Aveiro, Portugal.\', \'National Reference Laboratory for Influenza and other Respiratory Viruses, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/22221751.2020.1844552
?:doi
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 33131453
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all